22 results on '"Freeman, Leorah"'
Search Results
2. Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod (P6-6.006)
3. Relapse-associated Worsening and Progression-independent Relapse Activity in Ozanimod-treated Participants with Relapsing Multiple Sclerosis from the RADIANCE and DAYBREAK Trials (P6-6.014)
4. Use of Low Dose Naltrexone in a Cohort of Patients with Cryptogenic Small Fiber Neuropathy (P1-4.003)
5. Trends in Management Practices of Seropositive Neuromyelitis Optica Spectrum Disorder: Lessons from a Multicenter Academic Cohort (P10-14.010)
6. Small Fiber Neuropathy in People with MS with Neuropathic Pain and Dysautonomia: A Case Series (P9-4.005)
7. Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of MS DMTs: A Systematic Review (P4-4.011)
8. Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs
9. Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology
10. Treatment Patterns Among Patients With Multiple Sclerosis Newly Initiating Disease-Modifying Therapy (643)
11. Microglia activation in basal ganglia is a late event in Huntington’s disease pathophysiology (2626)
12. Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient
13. Decreased cerebral blood flow in the striatum is an early event in Huntington’s disease pathology (P1.8-044)
14. Exploring the relationship between brain atrophy and clinical symptoms in Huntington’s disease (S41.009)
15. Short-term brain damage accrual in African Americans with Multiple Sclerosis: MRI Findings from the CombiRx trial (S56.005)
16. Imaging outcome measures of neuroprotection and repair in MS
17. A young man in “double-trouble”: Hallucinations and cranial nerve palsies
18. A young man with numbness in arms and legs
19. Baseline cerebellar volume as short-term predictor of clinical disability in Multiple Sclerosis: MRI Findings from the CombiRx trial (S6.005)
20. Spontanous remyelination has a major impact on clinical disability in multiple sclerosis: a longitudinal PET study with 11C-PIB (S29.008)
21. Spontanous remyelination has a major impact on clinical disability in multiple sclerosis: a longitudinal PET study with 11C-PIB (I11-5D)
22. Predicting Confirmed Disability Progression In MS: Importance Of Early On-Treatment MRI Changes On Modeling The CombiRx Trial Database (P3.157)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.